The Hindu·3 min read·medium
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
A
AP
✦AI Summary
The FDA has approved Lipfendra, a new oral medication from Merck designed to lower cholesterol by blocking the PCSK9 protein. This pill offers a non-injectable alternative for high-risk patients who do not respond sufficiently to statins.
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in